Reports for SANDOZ CANADA INCORPORATED
Company Name
SANDOZ CANADA INCORPORATED
Totals |
||
Shortage reports |
1841 |
|
| Actual shortage: | 45 (2%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 13 (1%) | |
| Resolved: | 1782 (97%) | |
Discontinuation Reports |
82 |
|
| To be discontinued: | 1 (1%) | |
| Discontinued: | 79 (96%) | |
| Reversed: | 2 (2%) | |
Late reports |
439 (23%) |
|
Overdue reports |
3 (6%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| STALEVO | 125MG 31.25MG 200MG | TABLET | Resolved | 2021-03-02 | 2021-03-15 | 134914 |
| STALEVO | 100MG 25MG 200MG | TABLET | Resolved | 2021-03-22 | 2021-03-29 | 136070 |
| STALEVO | 75MG 18.75MG 200MG | TABLET | Resolved | 2021-04-12 | 2021-04-20 | 137321 |
| SUFENTANIL CITRATE INJECTION USP | 50MCG | SOLUTION | Resolved | 2022-09-01 | 2022-11-02 | 168449 |
| SUPEUDOL | 20MG | TABLET | Resolved | 2021-02-08 | 2021-03-09 | 133537 |
| SUPEUDOL | 20MG | TABLET | Resolved | 2022-05-24 | 2022-06-04 | 161184 |
| SUPEUDOL | 20MG | TABLET | Resolved | 2023-11-13 | 2023-11-21 | 210069 |
| SUPEUDOL 10 | 10MG | SUPPOSITORY | Resolved | 2022-09-01 | 2023-12-14 | 168433 |
| SUPEUDOL 5 | 5MG | TABLET | Resolved | 2021-03-15 | 2021-03-30 | 135633 |
| TIMOLOL MALEATE-EX | 0.25% | SOLUTION (EXTENDED RELEASE) | Resolved | 2019-09-25 | 2021-09-14 | 94633 |
| TIMOLOL MALEATE-EX | 0.50% | SOLUTION (EXTENDED RELEASE) | Resolved | 2019-12-10 | 2021-10-04 | 100873 |
| TIMOLOL MALEATE-EX | 0.25% | SOLUTION (EXTENDED RELEASE) | Resolved | 2022-06-22 | 2022-11-17 | 163223 |
| TIMOLOL MALEATE-EX | 0.25% | SOLUTION (EXTENDED RELEASE) | Resolved | 2023-03-13 | 2023-05-16 | 186993 |
| TIMOLOL MALEATE-EX | 0.5% | SOLUTION (EXTENDED RELEASE) | Resolved | 2023-12-19 | 2024-05-08 | 213825 |
| TIMOLOL MALEATE-EX | 0.25% | SOLUTION (EXTENDED RELEASE) | Actual shortage | 2024-05-13 | 2024-05-14 | 227853 |
| TOBRAMYCIN INHALATION SOLUTION | 300MG | SOLUTION | Resolved | 2017-03-14 | 2017-05-17 | 2553 |
| TOBRAMYCIN INHALATION SOLUTION | 300MG | SOLUTION | Resolved | 2018-02-05 | 2018-07-03 | 38757 |
| TOBRAMYCIN INHALATION SOLUTION | 300MG | SOLUTION | Resolved | 2020-11-27 | 2020-12-14 | 129111 |
| TOBRAMYCIN INHALATION SOLUTION | 300MG | SOLUTION | Resolved | 2021-01-12 | 2021-01-18 | 131408 |
| TOBRAMYCIN INHALATION SOLUTION | 300MG | SOLUTION | Avoided shortage | 2021-09-02 | 2021-09-14 | 145010 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ZOFRAN ODT | 8MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2022-12-08 | 2023-03-14 | 177540 |
| ZOFRAN ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2023-03-14 | 2023-03-14 | 187062 |